Vertigo relief app

📊 Full opportunity report: Vertigo relief app on IdeaNavigator AI — validation score, market gap, and execution plan.

TL;DR

Developers are creating a mobile app to assist adults with benign paroxysmal positional vertigo (BPPV) in performing repositioning maneuvers safely at home. The app targets patients and clinics, leveraging smartphone sensors and telehealth growth. Validation and clinical integration are ongoing.

Developers are working on a new mobile application designed to guide adults with recurrent positional vertigo (BPPV) through repositioning maneuvers at home, aiming to improve self-treatment accuracy and reduce relapse rates. The app could be recommended by ENT clinics, audiologists, and vestibular physiotherapists as a digital tool to support patient care between visits.

The proposed vertigo relief app will include screening features, animated step-by-step guides for maneuvers like Epley and Brandt-Daroff, and real-time head-angle feedback using smartphone gyroscope sensors. It logs dizziness episodes, triggers, and symptom severity over time, providing users and clinicians with valuable data.

According to sources close to the project, the app will operate on both iOS and Android platforms, with a freemium model offering basic guidance free of charge and advanced features such as detailed tracking and reminders available via subscription. Clinics could license the app for patient use, integrating it into their remote care offerings.

The initiative responds to the long-standing challenge that BPPV sufferers often perform repositioning maneuvers incorrectly at home, leading to recurrence in roughly half of cases. The COVID-19 pandemic accelerated demand for telehealth solutions, and smartphone sensors now provide sufficient accuracy for guided self-treatment, making this a timely development.

Potential Impact on BPPV Self-Management and Care

This app could significantly improve the self-treatment process for BPPV, reducing the need for frequent clinic visits and enabling better symptom management at home. By providing guided, real-time feedback, it aims to decrease recurrence rates and improve quality of life for patients, especially older adults, who represent the primary user base.

For clinics and healthcare providers, the app offers a scalable way to support patients remotely, potentially reducing wait times and increasing the efficiency of vestibular care. As digital therapeutics gain acceptance and reimbursement models mature, such tools could become standard components of vestibular disorder management.

Growing Demand for Digital Vestibular Rehabilitation

Benign paroxysmal positional vertigo (BPPV) is the most common vestibular disorder, yet many patients face long waits for specialist care and struggle with static diagrams when attempting self-treatment. The shift toward telehealth during the COVID-19 pandemic has accelerated interest in digital solutions for vestibular rehabilitation.

The market for digital therapeutics targeting dizziness and balance disorders was estimated near USD 498 million in 2024, with an expected compound annual growth rate of approximately 13.5% through 2033, reflecting increasing acceptance among both patients and payers. Smartphone sensors now enable accurate motion tracking, making guided self-treatment increasingly feasible.

“The integration of gyroscope sensors in smartphones provides a promising avenue for guiding patients through repositioning maneuvers at home with real-time feedback.”

— an anonymous researcher

Development Stage and Clinical Validation Still Unclear

It is not yet confirmed when the app will be available for public use, nor whether it will undergo formal clinical validation or regulatory approval. Plans for pilot testing, user feedback, and efficacy studies are still in progress.

Details about partnerships with clinics or health systems, and reimbursement pathways, remain to be announced.

Next Steps in App Development and Testing

Developers plan to launch a landing page and a no-code prototype of the guided Epley maneuver to gauge user interest and validate demand. They will run targeted marketing campaigns to vertigo search terms, measure engagement, and seek clinic partnerships for pilot programs.

Further, they intend to seek feedback from clinicians and patients to refine the app’s features before broader rollout and potential regulatory review.

Key Questions

When will the vertigo relief app be available to the public?

There is no confirmed release date yet. Development and testing are ongoing, with plans to pilot the app with clinics and users in the near future.

Can this app replace professional medical treatment for BPPV?

No. The app is designed to support self-treatment and should be used in conjunction with medical advice. It includes disclaimers emphasizing that it is not a substitute for professional care.

How does the app ensure the repositioning maneuvers are performed correctly?

The app uses smartphone gyroscope sensors to provide real-time head-angle feedback, animated step-by-step guidance, and audio cues to assist users in executing maneuvers accurately.

Will clinics be able to license the app for their patients?

Yes, there are plans to offer a clinic licensing tier that allows ENT, audiology, and physiotherapy practices to recommend or white-label the app for patient use between visits.

What evidence supports the effectiveness of digital tools like this for vertigo treatment?

While specific clinical validation for this app is pending, existing research indicates that guided self-rehabilitation with motion sensors can improve maneuver accuracy and reduce recurrence in BPPV patients.

Source: IdeaNavigator AI